secwatch.observer — SEC 8-K summary
======================================

Issuer:     NAVIDEA BIOPHARMACEUTICALS, INC. (—)
CIK:        0000810509
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001437749-23-017745
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Navidea declares Series K Preferred Stock dividend with super-voting rights on reverse split
--------------------------------------------------------------------------------

- Dividend of 1/1,000th of Series K Preferred per common share, record date June 27, 2023.
- Each Series K share carries 1,000,000 votes, voting only on a proposed reverse stock split.
- Series K non-transferable except with common shares; redeemed after reverse split vote.
- Dividend grants common holders extra voting power to facilitate reverse split approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/810509/000143774923017745/0001437749-23-017745-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/810509/000143774923017745/navb20230615_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-017745

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer